Glucocorticoids are a class of anti-inflammatory drugs commonly used to treat various ocular and systemic conditions. Although the role of glucocorticoids in the treatment of numerous serious inflammatory diseases is pivotal, their prolonged use may increase intraocular pressure resulting in steroid-induced glaucoma. We provide a detailed update on steroid-induced glaucoma as a preventable cause of blindness in the adult and pediatric population and describe its epidemiology, social impact, and risk factors. Furthermore, we explore the propensity of different steroids to increase the intraocular pressure, the role of different routes of steroid administration, dosage and duration of treatment, as well as the clinical features, genetics, and management of steroid-induced glaucoma.

Roberti, G., Oddone, F., Agnifili, L., Katsanos, A., Michelessi, M., Mastropasqua, L., et al. (2020). Steroid induced glaucoma: epidemiology, pathophysiology and clinical management. SURVEY OF OPHTHALMOLOGY, 65(4), 458-472 [10.1016/j.survophthal.2020.01.002].

Steroid induced glaucoma: epidemiology, pathophysiology and clinical management

Roberti G;Michelessi M;Manni G
Supervision
2020-01-01

Abstract

Glucocorticoids are a class of anti-inflammatory drugs commonly used to treat various ocular and systemic conditions. Although the role of glucocorticoids in the treatment of numerous serious inflammatory diseases is pivotal, their prolonged use may increase intraocular pressure resulting in steroid-induced glaucoma. We provide a detailed update on steroid-induced glaucoma as a preventable cause of blindness in the adult and pediatric population and describe its epidemiology, social impact, and risk factors. Furthermore, we explore the propensity of different steroids to increase the intraocular pressure, the role of different routes of steroid administration, dosage and duration of treatment, as well as the clinical features, genetics, and management of steroid-induced glaucoma.
2020
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/30 - MALATTIE APPARATO VISIVO
Settore MEDS-17/A - Malattie dell'apparato visivo
English
Roberti, G., Oddone, F., Agnifili, L., Katsanos, A., Michelessi, M., Mastropasqua, L., et al. (2020). Steroid induced glaucoma: epidemiology, pathophysiology and clinical management. SURVEY OF OPHTHALMOLOGY, 65(4), 458-472 [10.1016/j.survophthal.2020.01.002].
Roberti, G; Oddone, F; Agnifili, L; Katsanos, A; Michelessi, M; Mastropasqua, L; Quaranta, L; Riva, I; Tanga, L; Manni, G
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
2020. Steroid-induced glaucoma- Epidemiology, pathophysiology, and clinical management.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 558.29 kB
Formato Adobe PDF
558.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/256567
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 185
  • ???jsp.display-item.citation.isi??? 151
social impact